Dachaigh › Aillse sa bhlaire › Wisconsin › Milwaukee
Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an Milwaukee, WI
Tha aon sgrùdadh airson Aillse sa bhlaire a’ lorg phàirtichean aig làrach ann no faisg air Milwaukee. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- agus 9 a bharrachd
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
A’ fastadhÌre 2
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa, Wauwatosa · 5 mìle air falbh
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield · 10 mìle air falbh
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
A’ fastadhÌre 2
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa, Wauwatosa · 5 mìle air falbh
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield · 10 mìle air falbh
- agus 2 a bharrachd
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
A’ fastadhÌre 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- agus 7 a bharrachd
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Zablocki Veterans Administration Medical Center, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
A’ fastadh
- Froedtert Hospital, Milwaukee
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A’ fastadhÌre 1/2
- Froedtert Hospital / Medical College of Wisconsin, Milwaukee
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
A’ fastadhÌre 3
- Research Site, Milwaukee
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A’ fastadhÌre 2
- Froedtert Hospital/Medical College of Wisconsin, Milwaukee
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
A’ fastadhSgrùdadh amharc
- Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Milwaukee
Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile
- New York City, NY35 sgrùdaidhean
- Nashville, TN31 sgrùdaidhean
- Houston, TX31 sgrùdaidhean
- Dallas, TX27 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Washington, DC26 sgrùdaidhean
- Los Angeles, CA24 sgrùdaidhean
- Baltimore, MD24 sgrùdaidhean
- St. Louis, MO22 sgrùdaidhean
- Philadelphia, PA21 sgrùdaidhean
- Seattle, WA21 sgrùdaidhean
- Edison, NJ21 sgrùdaidhean
Sgrùdaidhean eile ann an Milwaukee
- Aillse a' bhroilleach23 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag22 sgrùdaidhean
- Aillse (gach seòrsa)22 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Myeloma iomaill21 sgrùdaidhean
- Aillse Prostata20 sgrùdaidhean
- Lymphoma follicular19 sgrùdaidhean
- Cancer Pancreatic18 sgrùdaidhean
- Liomfoma Neo-Hodgkin18 sgrùdaidhean
- Cancer Ovarian17 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Lymphoma Burkitt16 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.